Factors such as significant outsourcing of clinical trial research to CROs, rising number of clinical trials, availability of advanced CTMS solutions, and rising government funds & grants to support clinical trials are driving the overall demand for CTMS across key markets.
The global clinical trial management system market is expected to reach USD 1,065.6 Million by 2022 from USD 534.1 Million in 2016, at a CAGR of 12.6%.
The time frame considered for the study are as follows:
Base Year: 2016
Forecast Period: 2017–2022
Download the PDF Brochure for More Details@
Objectives of the study are:
# To define, describe, segment, and forecast the global clinical trial management systems market by type, delivery mode, component, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the global CTMS market (drivers, restraints, opportunities, and challenges)
# To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
# To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
# To forecast the market value of market segments with respect to the four key regions, namely, North America (US, and Canada), Europe (Germany, UK, France and RoE), Asia Pacific (China, Japan, India and RoAPAC), and the Rest of the World
# To profile the key players in the global CTMS market and comprehensively analyze their market rank and core competencies
# To track and analyze competitive developments such as product launches and enhancements; partnerships, agreements, and collaborations; mergers and acquisitions; and expansions in the global clinical trial management system market
North America is expected to dominate the CTMS market during the forecast period
Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2022). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.
Read the Detailed Article@
The major players operating in the CTMS market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).
Stakeholders:
# Healthcare IT service providers
# Pharmaceutical/biopharmaceutical companies
# Clinical research organizations
# Research and development (R&D) companies
# Medical device companies
# Business research and consulting service providers
Academic medical centers/universities/hospitals
No comments:
Post a Comment